Life Sciences and Healthcare Briefing: Covid-19 Special Edition

Our Life Sciences and Healthcare Briefing provides an overview of changes introduced to life sciences and healthcare law by new legislation arising out of the Covid-19 pandemic, including:

  • Prohibition of Profit Margin Increases for Pharmaceuticals and Personal Hygiene Products
  • Obligation of Pharmaceutical and Healthcare Companies to Declare their Stocks of Surgical Masks, Antiseptic Solutions and Antiseptic Wipes
  • Special Purpose Leave for Employees in Pharmaceutical and Paramedical Companies
  • Reduction of VAT Rate Applicable to Personal Hygiene and Protection Products
  • Maximum Quantities of Personal Protection and Hygiene Products
  • Donations and Requisition of Medicines and Hospital Medical Equipment
  • Urgent Invitation for Purchase of Medical Devices by Way of Derogation of Public Procurement Provisions
  • Electronic Prescription and Delivery of Medicines Approval of Technical Specifications for Urgent Supplies for Vital Public Health Needs
  • Prohibition of Exports of Paracetamol and Products Necessary for the Treatment of Covid-19 and Electronic Submission of Requests to the EOF.

Click here to read the Briefing.

Life Sciences and Healthcare Briefing: Covid-19 Special Edition

Read next